Beta2 agonists and heart failure.
Lindmark
B
B
Ottosson
A
A
D058666:Adrenergic beta-2 Receptor Agonists; D000318:Adrenergic beta-Agonists / Q000009:adverse effects*; D000420:Albuterol / Q000009:adverse effects / Q000031:analogs & derivatives*; D019317:Evidence-Based Medicine; D006333:Heart Failure / Q000139:chemically induced*; D006801:Humans; D011358:Product Surveillance, Postmarketing; D012107:Research Design / Q000592:standards*; D000068299:Salmeterol Xinafoate; D013726:Terbutaline / Q000009:adverse effects / Q000031:analogs & derivatives*
D058666:Adrenergic beta-2 Receptor Agonists; D000318:Adrenergic beta-Agonists; D000068299:Salmeterol Xinafoate; D013726:Terbutaline; D000420:Albuterol; C047766:bambuterol